Marrone Bio Upsizes IPO
Marrone Bio Innovations increased its IPO, but priced lower than planned. CEO Pam Marrone talks about the company's future.
Disclosure: TheStreet's editorial policy prohibits staff editors, reporters and analysts from holding positions in any individual stocks.
